FH
Form Health
Physician-led obesity medicine
Accepts Insurance HSA/FSA Eligible
Starting at
$149
Rx
Yes
States
50
- Board-certified U.S. licensed clinicians
- Transparent flat-rate pricing
Providers listed
5
Avg starting price
$87
Price range
$19–$149
Insurance accepted
100%
States covered
50
What is Tirzepatide?
Tirzepatide is a dual GLP-1/GIP receptor agonist marketed as Mounjaro (diabetes) and Zepbound (weight loss).
How we verify Tirzepatide providers
Our editorial team evaluates every provider on cost transparency, clinician licensure, prescribing rigor, HIPAA compliance, and real patient experience — never accepting payment for rankings.
Who this medication is for
This medication is designed for U.S. residents comparing legitimate, licensed telehealth options for tirzepatide. We keep this page current with new provider launches, price changes, and regulatory updates.
Recently researched
Tirzepatide: recently researched providers
HE
Hers
Women's telehealth for skin, hair, mental, weight
Accepts Insurance HSA/FSA Eligible
Starting at
$39
Rx
Yes
States
50
- Board-certified U.S. licensed clinicians
- Transparent flat-rate pricing
LI
LifeMD
Multi-service telehealth membership
Accepts Insurance HSA/FSA Eligible
Starting at
$19
Rx
Yes
States
50
- Board-certified U.S. licensed clinicians
- Transparent flat-rate pricing
Side-by-side
Compare your options
| Provider | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
FH Form Health Physician-led obesity medicine | Starting at$149/mo | 50 | 4.6 | 4.4 | 2026-08-27 | |||||
Hers Women's telehealth for skin, hair, mental, weight | Starting at$39/mo | 50 | 4.6 | 4.4 | 2026-08-26 | |||||
LifeMD Multi-service telehealth membership | Starting at$19/mo | 50 | 4.3 | 4.1 | 2026-08-27 | |||||
PlushCare Board-certified physicians, insurance accepted | Starting at$129/mo | 50 | 4.4 | 4.2 | 2026-08-26 | |||||
Sequence GLP-1 access through Weight Watchers | Starting at$99/mo | 47 | 4.4 | 4.1 | 2026-08-27 |
How we researched this pageInformation checked 2026-02-01Reviewed by Dr. Sarah Chen, MDSources: provider sites, state medical boards, FDAEditorial methodology →
Knowledge graph
Explore what connects
Related conditions
FAQs